Department of Anesthesiology, Beijing Tong Ren Hospital, Capital Medical University, Beijing, 100730, China.
Department of Surgery, Stony Brook University, Stony Brook, NY, USA.
Crit Care. 2017 Jun 12;21(1):141. doi: 10.1186/s13054-017-1728-8.
Goal-directed hemodynamic therapy (GDHT) has been used in the clinical setting for years. However, the evidence for the beneficial effect of GDHT on postoperative recovery remains inconsistent. The aim of this systematic review and meta-analysis was to evaluate the effect of perioperative GDHT in comparison with conventional fluid therapy on postoperative recovery in adults undergoing major abdominal surgery.
Randomized controlled trials (RCTs) in which researchers evaluated the effect of perioperative use of GDHT on postoperative recovery in comparison with conventional fluid therapy following abdominal surgery in adults (i.e., >16 years) were considered. The effect sizes with 95% CIs were calculated.
Forty-five eligible RCTs were included. Perioperative GDHT was associated with a significant reduction in short-term mortality (risk ratio [RR] 0.75, 95% CI 0.61-0.91, p = 0.004, I = 0), long-term mortality (RR 0.80, 95% CI 0.64-0.99, p = 0.04, I = 4%), and overall complication rates (RR 0.76, 95% CI 0.68-0.85, p < 0.0001, I = 38%). GDHT also facilitated gastrointestinal function recovery, as demonstrated by shortening the time to first flatus by 0.4 days (95% CI -0.72 to -0.08, p = 0.01, I = 74%) and the time to toleration of oral diet by 0.74 days (95% CI -1.44 to -0.03, p < 0.0001, I = 92%).
This systematic review of available evidence suggests that the use of perioperative GDHT may facilitate recovery in patients undergoing major abdominal surgery.
目标导向性血流动力学治疗(GDHT)在临床环境中已经使用了多年。然而,GDHT 对术后恢复有益效果的证据仍然不一致。本系统评价和荟萃分析的目的是评估与常规液体治疗相比,围手术期 GDHT 对接受大型腹部手术的成年人术后恢复的影响。
研究人员评估了围手术期使用 GDHT 对接受腹部手术(即 >16 岁)的成年人术后恢复的影响与常规液体治疗相比的随机对照试验(RCT)被认为是合适的。计算了具有 95%置信区间(CI)的效应大小。
纳入了 45 项符合条件的 RCT。围手术期 GDHT 与短期死亡率(风险比 [RR] 0.75,95% CI 0.61-0.91,p = 0.004,I = 0)、长期死亡率(RR 0.80,95% CI 0.64-0.99,p = 0.04,I = 4%)和总体并发症发生率(RR 0.76,95% CI 0.68-0.85,p < 0.0001,I = 38%)显著降低相关。GDHT 还促进了胃肠道功能的恢复,表现为首次排气时间缩短 0.4 天(95% CI -0.72 至 -0.08,p = 0.01,I = 74%)和耐受口服饮食时间缩短 0.74 天(95% CI -1.44 至 -0.03,p < 0.0001,I = 92%)。
对现有证据的系统评价表明,围手术期 GDHT 的使用可能有助于接受大型腹部手术的患者的康复。